baber/WOPTO huggingface dataset:
Patent NZ-300400-A (NZ)
Title: (s)-enantiomeric methanesulphonamide derivatives useful in treating cardiac arrhythmia
Inventor: HESTER JACKSON B
IPC: A61K31/18
Filed: 1995-12-21
Abstract: (S)-Enantiomeric methanesulfonamides are structurally depicted by formula (I) or its pharmacologically acceptable salts where R3 is a C1-9 alkyl substituted with one fluorine atom. These compounds are useful as Class III antiarrhythmic agents without the undesirable side effect of polymorphic ventricular tachycardia (PVT) and are stable against rapid metabolism. Use of the compounds of formula (I) in the preparation of compositions for treating cardiac arrhythmias are also described.
Patent NZ-338076-A (NZ)
Title: Synthetic composite closure with foamed plastics inner and outer cores
Inventor: NOEL GERT
IPC: B65D39/00
Filed: 1998-04-13
Abstract: A foamed plastic inner core has density of 100 to 500 kg/m3  and a foamed outer portion has density of 300 to 1500 kg/m3 . The outer portion in use, frictionally engages a surface of the portal formed in the neck of a bottle (not shown).
Patent NZ-503160-A (NZ)
Title: Aqueous aerosol preparations containing biologically active macromolecules such as insulin, interferon or superoxide dismutase
Inventor: REIMHOLZ RALPH CHRISTIAN
IPC: A61K9/12
Filed: 1998-07-31
Abstract: An aqueous preparation of an active substance in the form suitable for administration to a human subject by inhalation wherein the active substance is present in a concentration of 25-100 mg/ml and is antisense oligonucleotides, orexins, erythropoetin, a-tumour necrosis factor, b-tumour necrosis factor, granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, annexins, calcitonin, leptins, parathyrin fragments, interleukins, insulin, superoxide distmutase, an interferon, soluble intercellular adhesion molecule, somatostatin, somatotropin, tissue plasminogen activator, tumour associated antigens, peptide bradykinin antagonists, urodilatin, growth hormone releasing hormone, corticotropin releasing factor, EMAP II, heparin, soluble interleukin receptors, vaccines, antisense polynucleotides and transcription factors provided that the concentration of  granulocyte colony stimulating factor is other than 25 mg/ml.  The aqueous preparation produces inhalable aerosols without the need for propellant gases.
Patent NZ-519433-A (NZ)
Title: A calcium absorption enhancing agent and a method for producing it
Inventor: KUMAGAI HITOMI
IPC: A23L1/305
Filed: 2000-08-29
Abstract: A calcium absorption enhancing agent is described. The agent is produced by subjecting a vegetable protein to at least a treatment of removing a phytate with an anion exchange resin and a deamidation treatment with a weakly acidic cation exchange resin. The treatment is conducted at a temperature in the range of 0 - 50oC. Also disclosed is a calcium enriched food, a pharmaceutical preparation, and a nutrition composition containing this agent.
Patent NZ-520298-A (NZ)
Title: Cook-top having a transparent untinted glass ceramic plate
Inventor: KRAUSE CORA
IPC: B44C5/04
Filed: 2001-02-15
Abstract: Modern cook-tops comprising of a colored glass ceramic plate (1) serving as a cooking surface, which has cooking zones (2) that are heated by radiant heating elements (3), and on whose top side decorations are applied are disclosed. In order to obtain particularly brilliant decorations while providing a smooth cooking surface of the glass ceramic plate (1), said glass ceramic plate (1) is comprised of a non-colored transparent glass ceramic material, whereby the decorations consisting of temperature- resistant coloring substances are applied as IR-permeable coatings (6) only to the underside of the glass ceramic plate (1). The decorations, when viewed from above, thus display brilliant shapes like a rear surface glass painting, and the cooking surface side of the glass ceramic plate (1) remains smooth.
Patent NZ-520393-A (NZ)
Title: Effervescent dual component toothpaste composition comprising an alkali metal bicarbonate, an acid and alkyl vanillyamide (capsaicin
Inventor: MASTERS JAMES G
IPC: A61K8/19
Filed: 2001-01-17
Abstract: A two component effervescent dentifrice composition comprises a first alkali metal bicarbonate containing dentifrice component and a second acid containing dentifrice component; the first and second component are separated prior to use wherein the effervescent signal generated upon the combination and mixing of the components is enhanced by the presence in the combined components of a naturally occurring alkyl vanillyamide. The presence of the alkyl vanillyamide provides a unique and consumer measurable sensation during brushing instilling in the consumer a perception of enhanced product cleaning performance. Preferably the alkyl vanillyamide is capsaicin, alkali metal bicarbonate is sodium bicarbonate and the second acid-containing dentifrice component contains phosphoric acid. Also described is a method for enhancing sensory signal from an effervescent dentifrice.
Patent NZ-527370-A (NZ)
Title: Novel gum application in wheyless cream cheese systems
Inventor: CHA ALICE SHEN
IPC: A23C19/028
Filed: 2003-08-01
Abstract: A process for making a wheyless cream cheese or wheyless cream cheese-product, comprising: (1) providing a dairy mixture containing dairy proteins and fat, (2) heating the dairy mixture to a temperature from 120 to 160°F to form a first heated dairy mixture, (3) homogenizing the first heated dairy mixture to form a first homogenized dairy mixture, (4) heating the first homogenized dairy mixture to 165 to 215°F for 15 seconds to 20 minutes to form a heated dairy mixture, (5) cooling the second heated dairy mixture to a temperature of 65 to 80°F to form a cooled dairy mixture, (6) inoculating the cooled dairy mixture with a lactic ferment starter culture to form an inoculated dairy mixture, (7) incubating the inoculated dairy mixture to reduce the pH to 4.3 to 5 to form a cultured dairy mixture, (8) adjusting the pH of the cultured dairy mixture to 4.6 to 5.3 to form a cultured diary blend, (9) heating the cultured dairy blend at 180 to 205°F for 15 seconds to 30 minutes to form a heated, cultured dairy blend, and (10) homogenizing the heated, cultured dairy blend to form the wheyless cream cheese or wheyless cream cheese-like product, wherein an effective amount of an ionic gum is added during or before the incubating step (7).
Patent NZ-528104-A (NZ)
Title: Method and apparatus for tracing components of a production chain
Inventor: BAIRD KENNETH JAMES
IPC: G05B15/02
Filed: 2002-02-19
Abstract: A method of tracking, at a remote central information store (140), elements in a production chain, the chain comprising a plurality of processes (20, 40, 60, 80, 100, 120) each process having one or more input ingredients (10, 30, 50, 70, 90, 110) and one or more output products (30, 50, 70, 90, 110, 130) and the central information store (140) is remote from the location of at least one of the processes, comprises: (1) recording at the remote central information store (140), via a telecommunications link, an identifier identifying each of the input ingredients (20, 40, 60, 80, 100, 120) of the process; (2) marking each of the output products (30, 50, 70, 90, 110, 130) of the process with a respective identifier ; and (3) recording at the remote central information store (140), via a telecommunications link, the identifiers of each of the output products (30, 50, 70, 90, 110, 130).
Patent NZ-531534-A (NZ)
Title: Angiotensin peptides conjugated with a carrier comprising a virus-like particle
Inventor: BACHMANN MARTIN
IPC: A61K38/095
Filed: 2002-10-07
Abstract: An angiotensin peptide moiety-carrier conjugate comprises: (a) a carrier with at least one first attachment site and (b) at least one angiotensin peptide moiety with at least one second attachment site. The carrier comprises a core particle that is a virus-like particle and the second attachment site is capable of association through at least one covalent bond to the first attachment site to form an ordered and repetitive angiotensin peptide moiety-carrier conjugate. Pharmaceutical and vaccine composition comprising the conjugate are described. The compositions are useful for treating disorders associated with rennin-activated angiotensin system such as hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage.
Patent NZ-535870-A (NZ)
Title: A secure information storage system using data splitting and separated storage with encryption
Inventor: TUNE ANDREW DOMINIC
IPC: G06Q20/10
Filed: 2003-04-11
Abstract: A system for storing information having a predetermined use which requires the information to be secured. The information may comprise credit card details used to complete a transaction. The system includes: (a) A client system for storing an encoded version of the information and an identifier. The encoded version is generated from first data of the information and an encoded version of the second data of the information. The information can be generated from the first data and the second data, and the predetermined use is infeasible with only one of the first data and the second data. (b) A remote server for storing the second data and an encoded identifier generated from the identifier. The client system sends at least the encoded version of the second data to the remote server. The client system or the remote server is able to generate the information from the first data and the second data. Accordingly, only part of the information to be secured is stored locally on the client system, whilst the other part is stored on the remote server, and neither the client system nor the remote server have a record of the entire information.
Patent NZ-540831-A (NZ)
Title: Container for containment and transport of objects
Inventor: MACASAET ALEXANDER
Filed: 2004-04-08
Abstract: A container (38) including at least three sidewalls (24) with corners (28) there between defining an internal space for storage of at least one item, the sidewalls having an open base and an open top. The sidewalls are foldable about the corners for ease of storage. There is also a cover (36) for the internal space; and a pallet (40) onto which the sidewalls can be placed. The sidewalls have at least one perforated line (26, 30, 32) to enable the height of the sidewalls to be varied.
Patent NZ-547966-A (NZ)
Title: Multilayer coextruded films including frangible intralaminar bonding forces
Inventor: BUSCHE DAVID A
Filed: 2006-06-15
Abstract: A multilayer coextruded thermoplastic film structure is disclosed, which comprises in the following order: (a) a first layer comprising a polymer sealant material; (b) a second layer comprising a frangible polymer blend; (c) a third layer comprising an adhesive material; (d) a fourth layer comprising a nylon; (e) a fifth layer comprising a member selected from the group consisting of an adhesive material and an oxygen gas barrier material; (f) a sixth layer comprising a nylon; (g) a seventh layer comprising an adhesive material; and (h) an eighth layer comprising a member selected from the group consisting of polyethylene, polypropylene, polyester, nylon and blends and copolymers thereof; wherein said first layer is coextruded with said second through eighth layers, said first layer comprises from about 1% to about 10% of the total thickness of said coextruded film structure, said first layer has a thickness uniformity deviation of less than about 20% of the average thickness of said first layer; said second layer has a maximum thickness of about 0.5 mils.; and said multilayer film structure has a peel strength of less than 2000 grams per inch as measured in accordance with ASTM F-904 test method when peeled from a second film structure to which said multilayer film structure has been heat-sealed.
Patent NZ-548862-A (NZ)
Title: New crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
Inventor: COQUEREL GERARD
Filed: 2006-08-01
Abstract: Crystalline form III of agomelatine (N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide) is disclosed, wherein the crystalline form III of agomelatine has powder X-ray diffraction diagram, measured using a diffractometer (copper anticathode) and expressed in terms of inter-planar distance d (8.405-3.024 A[deg]), Bragg's angle 2 theta (10.52-29.51 degrees), intensity and relative intensity (expressed as a percentage with respect to the most intense ray). A process for the preparation of the crystalline form III of agomelatine is also disclosed, wherein agomelatine is heated at 110[deg.] C until fully melted, and then slowly cooled until crystallisation occurs. A pharmaceutical composition comprising as active ingredient an effective amount of crystalline form III of agomelatine is suitable for treating sleep disorders, stress, anxiety, seasonal affective disorders or severe depression, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue due to jetlag, schizophrenia, panic attacks, melancholia, appetite disorders, obesity, insomnia, psychotic disorders, epilepsy, diabetes, Parkinson's disease, senile dementia, various disorders associated with normal or pathological ageing, migraine, memory loss, Alzheimer's disease, cerebral circulation disorders, and also in sexual dysfunction, as ovulation inhibitors, immunomodulators and cancers.
Patent NZ-552363-A (NZ)
Title: Liquid container with dual flow dispensing valve
Inventor: BEALE GLENN ROBERT
Filed: 2007-01-03
Abstract: A container for the storage, transport and dispensing of low viscosity liquids; said container provided with at least one raised feature on a first surface of said container and at least one corresponding indented feature on a second opposite surface of said container; said at least one raised feature and said at least one indented feature adapted to the interlocked stacking of said containers; said container further provided with a dual flow liquid dispensing means projecting from a recessed portion of an end surface of said container: said dual flow dispensing means adapted for outflow of said liquid and inflow of air.
Patent NZ-553983-A (NZ)
Title: Replikin peptides and uses thereof
Inventor: BOGOCH SAMUEL
IPC: C07K14/44
Filed: 2002-07-09
Abstract: Provided are isolated or synthesized peptides consisting of from 7 to about 50 amino acids wherein said peptide is isolated or selected for synthesis by identifying a motif consisting of: (1) at least one lysine residue located at a first terminus of said motif and at least one lysine residue or at least one histidine residue located at a second terminus of said motif; (2) a first lysine residue located six to ten residues from a second lysine residue; (3) at least one histidine residue; and (4) at least 6% lysine residues; selecting said identified motif and isolating or synthesizing said peptide consisting of said identified motif. The peptide is a HIV virus peptide or another specified viral, bacterial, fungal, algal, yeast, amoeba or plant peptide, or a structural replication-associated peptide. Further provided are methods to increase replication in various organisms by transforming replication function genes with a nucleic acid sequence encoding the said peptide(s). Also provided are antibodies to the claimed peptides and use of the antibodies for the manufacture of medicaments to treat malaria,
Patent NZ-555239-A (NZ)
Title: High yield method of producing pure rebaudioside A
Inventor: JACKSON MEL CLINTON
IPC: A23L19/00
Filed: 2005-10-18
Abstract: Provided is a method of purifying rebaudioside A from Stevia starting material, comprising using a selected EtOH solvent, with successive refluxes of increasing water content. Further provided is 99% pure rebaudioside A and various composition comprising the purified rebaudioside A.
Patent NZ-567432-A (NZ)
Title: A patient interface system with an interfacing structure including an unskinned foam surface
Inventor: KWOK PHILIP RODNEY
IPC: A61M16/00
Filed: 2007-07-27
Abstract: Disclosed is a patient interface system (30) for providing a supply of air from a source of air at positive pressure to the entrance to the airways of a patient. The system (30) comprises an interfacing structure (20) and manifold (70). The interfacing structure (20) includes unskinned foam surface for contacting the patient's skin. The manifold (70) is adapted to connect with the supply of positive air pressure. There is at least one tube (42) that is connected to the manifold (70) and adapted to deliver the supply of air to the interfacing structure (20). The at least one tube (42) is structured to allow movement between an open phase in which the tube (42) allows the passage of air and a collapsed phase in which the tube (42) is collapsed. The at least one tube (42) is structured such that weight of a typical patient's head against bedding apparel is sufficient to collapse the tube (42) from the open phase to the collapsed phase.
Patent NZ-570604-A (NZ)
Title: Sterilized nanoparticulate glucocorticosteroid formulations
Inventor: SHAW JACK MICHAEL
IPC: A61K31/57
Filed: 2007-01-24
Abstract: Disclosed is a sterile dispersion composition comprising: (a) particles of at least one glucocorticosteroid, wherein the particles have an effective average particle size of less than about 2000 nm; (b) at least one nonionic surface stabilizer; and (c) at least one amphiphilic lipid; wherein the composition is sterilized by moist heat sterilization. Also disclosed are the use of said composition for treating inflammatory diseases such as asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and emphysema.
Patent NZ-579029-A (NZ)
Title: Industrial method for the synthesis of 17-acetoxy-11-beta-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process
Inventor: BODI JOZSEF
IPC: C07J51/00
Filed: 2008-06-19
Abstract: Disclosed is a process for the synthesis of 17-acetoxy-11-beta-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione of formula (I) from 3,3-[1,2-etandiyl-bis(oxy)]-oestr-5(10),9(l l)-dien-17-one of formula (II).
Patent NZ-580447-A (NZ)
Title: Suspension formulations of insulinotropic peptides and uses thereof
Inventor: ALESSI THOMAS R
IPC: A61K9/16
Filed: 2008-04-22
Abstract: Disclosed is a suspension formulation comprising a particle formulation comprising an insulinotropic peptide, a disaccharide, methionine, and a buffer; wherein (i) the insulinotropic peptide is a glucagon-like peptide-1 (GLP-1), a derivative of GLP-1, an analogue of GLP-1, exenatide, a derivative of exenatide, or an analogue of exenatide, and (ii) the weight percent ratio of insulinotropic peptide to methionine+disaccharide in particles of the particle formulation is between 1/10 to 10/1; and a non-aqueous, single-phase suspension vehicle that consists essentially of about 20 wt% to about 60 wt% benzyl benzoate and about 80 wt% to about 40 wt% polyvinylpyrrolidone, the suspension vehicle having a viscosity of between about 12,000 to about 18,000 poise at 33oC; wherein the suspension vehicle exhibits viscous fluid characteristics, and the particle formulation is dispersed in the vehicle. Further disclosed are osmotic delivery devices comprising said suspension formulations and uses thereof of said suspension formulations.
Patent NZ-581606-A (NZ)
Title: Novel macrocyclic inhibitors of hepatitis c virus replication
Inventor: BLATT LAWRENCE M
IPC: A61K31/407
Filed: 2008-05-02
Abstract: Disclosed is a compound having the structure of Formula I e.g. (2R,6S,13aS,14aR,16aS,z} -14a-(cyclopropylsulfonylcarbamoyl)-6-(4-fluorophenylamino)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11, 13a,14,14a,15,16,16ahexadecahydrocyclopropa[e]pyrrolo [1,2-a][1,4] diazacyclopentadecin-2-yl fluoroisoindoline-2-carboxylate or a pharmaceutically acceptable salt thereof wherein R1, Z1, Z2, R2, R3, R11 and R12 are defined in the specification for treating hepatitis C infection.
Patent NZ-583086-A (NZ)
Title: Insecticides for increasing the crop yield
Inventor: BRAHM LUTZ
IPC: A01P7/04
Filed: 2008-08-15
Abstract: Disclosed herein is the use of fipronil for increasing the crop yield of wheat which is growing in soil which is supplied with less than 70%, particularly less than 50%, of standard nitrogen fertilization, relative to the total need for nitrogen of the specific crop, where the crop yield is increased in the presence or absence of insect pest pressure. Also disclosed is a method for increasing the crop yield of wheat which is growing in soil which is supplied with less than 70%, particularly less than 50%, of standard nitrogen fertilization, relative to the total need for nitrogen of the specific crop, which method comprises treating the plan propagules from which the wheat plant is to grow with fipronil, where the crop yield is increased in the presence or absence of insect pest pressure.
Patent NZ-585509-A (NZ)
Title: Methods and devices for the detection of hypopnea
Inventor: ARMISTEAD JEFFREY PETER
IPC: A61B5/087
Filed: 2010-05-21
Abstract: A hypopnea detection apparatus (11) comprises a controller having at least one processor to access data representing a measured flow of breathable gas. The controller (104) is further configured to determine a first measure from a short-term measure of ventilation of the data; determine a second measure from a long-term measure of ventilation of the data; compare the first measure with first and second proportions of the second measure; and indicate a detection of the hypopnea based on the comparing if the first measure falls below the first proportion and does not subsequently exceed a range of the first and second proportions during a first time period. The short-term measure of ventilation is a short term variance of the data and the long-term measure of ventilation is a long-term variance of the data.
Patent NZ-585957-A (NZ)
Title: Sandal with spring loaded heel strap
Inventor: SOMERVILLE JAMES NEVILLE
IPC: A43B3/12
Filed: 2008-12-11
Abstract: Footwear 2 including a sole 4 for supporting a foot, a vamp 8 extending from the sole 4, and a heel restraint 10 extending from either side of the vamp 8. The heel restraint 10 includes biasing means 16a for biasing the heel restraint 10 to extend around the upper heel of the foot so that the foot is restrained from slipping from the footwear 2. The heel restraint 10 is configured to be moved from the upper heel and toward the sole 4 so that the foot can be slipped from the footwear 2. The heel restraint 10 includes a heel strap 20. The biasing means 16a is integrally formed with the heel strap 20.
Patent NZ-586309-A (NZ)
Title: Arrangement for obtaining a representative milking sample with circulating pump for stirring milk
Inventor: GUDMUNDSSON MATS
IPC: B01F25/50
Filed: 2009-01-27
Abstract: The present invention relates to milking stations and methods of providing samples of milk, and in particular it concerns providing milk samples being representative for analysis of the milk, in particular its fat content. An arrangement in a milking station (1) comprises at least one receiver (3) adapted to contain the milk from the animal being milked during a milking session, a means for extracting milk (2, 4) from the animal into the receiver (3) and a means (17) for transferring milk from the receiver to a sample unit (21). To provide a representative sample of milk, the arrangement comprises a pump (5) and a circulation line (9) extending from the receiver via the pump (5) and back to the receiver, for stirring the milk in the receiver. The arrangement is used to stir essentially all of the extracted milk before a sample part is transferred from the receiver (3) to the milk-sampling unit (5) to ensure that the sampled part is representative of the milk from one animal.